The litigation, filed by the DJS Law Group, focuses on alleged violations of the Securities Exchange Act of 1934 between February 28, 2024, and February 25, 2026. According to the court filing, the company’s practice of pulling sales into earlier quarters created artificial growth patterns that masked underlying inventory issues. Shareholders who suffered losses during this timeframe are now being sought to serve as lead plaintiffs in the ongoing case.
Investors File Securities Class Action Against PROCEPT BioRobotics
A federal class action lawsuit alleges PROCEPT BioRobotics misled investors by inflating revenue through aggressive discounting tactics. The complaint claims the company pulled sales forward from future periods, resulting in a significant inventory glut that rendered its public financial disclosures false and materially misleading throughout the two-year class period.
David J. Schwartz, lead attorney at DJS Law Group, is managing the outreach for potential claimants. While the deadline for seeking lead plaintiff status is September 22, 2026, the firm notes that investors are not required to hold a formal leadership position to participate in a potential financial recovery. Investors looking to join the action or discuss their legal standing can reach the firm at their Eastchester, New York office.
Comments (0)
No comments yet. Be the first!